* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Friday, August 1, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    Sens. Blackburn, Warnock introduce CREATE Act to provide tax relief to music creators – Yahoo Home

    Sens. Blackburn and Warnock Launch CREATE Act to Deliver Tax Relief for Music Creators

    That’s (Political) Entertainment: When Theatre Meets Politics

    Future Script: How Generative AI Is Changing Collective Bargaining in the Entertainment Industry – Jackson Lewis

    Future Script: How Generative AI Is Transforming Collective Bargaining in Entertainment

    The SBA’s live-entertainment bailout was supposed to end two years ago. We still don’t know how $1.5 billion was spent. – Yahoo Home

    $1.5 Billion Live-Entertainment Bailout: Two Years Later, Where Did the Money Go?

    Wall Street Bets: Caesars, Golden Entertainment, Churchill Downs, GLPI, Boyd – CDC Gaming

    Top Wall Street Bets: Caesars, Golden Entertainment, Churchill Downs, GLPI, and Boyd Take Center Stage

    Micro wrestling coming to NE Ohio – Cleveland.com

    Get Ready, NE Ohio: Micro Wrestling Is Making Its Exciting Debut!

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Emory orthopaedic surgeons use robotic technology to transform knee replacement surgery – Emory News Center

    How Robotic Technology is Revolutionizing Knee Replacement Surgery

    Cognizant Technology Solutions Corp (CTSH) Q2 2025 Earnings Call Highlights: Strong Revenue … – Yahoo.co

    Cognizant Q2 2025 Earnings: Impressive Revenue Growth and Key Takeaways

    Revving Up The U.S. Technology Engine – Forbes

    Revving Up The U.S. Technology Engine – Forbes

    More than just a hockey player – Rochester Institute of Technology Athletics

    Beyond the Ice: The Inspiring Journey of a Remarkable Athlete from Rochester Institute of Technology

    Smart Logistics in Warehousing – From Legacy Protocols to Green IoT – How Technology Is Reshaping the Sustainable Supply Chain – Logistics Viewpoints –

    Smart Logistics in Warehousing – From Legacy Protocols to Green IoT – How Technology Is Reshaping the Sustainable Supply Chain – Logistics Viewpoints –

    AI’s race in the dark with China – Axios

    The High-Stakes AI Race: Innovation and Competition in the Shadows

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    Sens. Blackburn, Warnock introduce CREATE Act to provide tax relief to music creators – Yahoo Home

    Sens. Blackburn and Warnock Launch CREATE Act to Deliver Tax Relief for Music Creators

    That’s (Political) Entertainment: When Theatre Meets Politics

    Future Script: How Generative AI Is Changing Collective Bargaining in the Entertainment Industry – Jackson Lewis

    Future Script: How Generative AI Is Transforming Collective Bargaining in Entertainment

    The SBA’s live-entertainment bailout was supposed to end two years ago. We still don’t know how $1.5 billion was spent. – Yahoo Home

    $1.5 Billion Live-Entertainment Bailout: Two Years Later, Where Did the Money Go?

    Wall Street Bets: Caesars, Golden Entertainment, Churchill Downs, GLPI, Boyd – CDC Gaming

    Top Wall Street Bets: Caesars, Golden Entertainment, Churchill Downs, GLPI, and Boyd Take Center Stage

    Micro wrestling coming to NE Ohio – Cleveland.com

    Get Ready, NE Ohio: Micro Wrestling Is Making Its Exciting Debut!

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Emory orthopaedic surgeons use robotic technology to transform knee replacement surgery – Emory News Center

    How Robotic Technology is Revolutionizing Knee Replacement Surgery

    Cognizant Technology Solutions Corp (CTSH) Q2 2025 Earnings Call Highlights: Strong Revenue … – Yahoo.co

    Cognizant Q2 2025 Earnings: Impressive Revenue Growth and Key Takeaways

    Revving Up The U.S. Technology Engine – Forbes

    Revving Up The U.S. Technology Engine – Forbes

    More than just a hockey player – Rochester Institute of Technology Athletics

    Beyond the Ice: The Inspiring Journey of a Remarkable Athlete from Rochester Institute of Technology

    Smart Logistics in Warehousing – From Legacy Protocols to Green IoT – How Technology Is Reshaping the Sustainable Supply Chain – Logistics Viewpoints –

    Smart Logistics in Warehousing – From Legacy Protocols to Green IoT – How Technology Is Reshaping the Sustainable Supply Chain – Logistics Viewpoints –

    AI’s race in the dark with China – Axios

    The High-Stakes AI Race: Innovation and Competition in the Shadows

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

All-Oral AML Regimen Shows Promise for Older, Unfit Patients

March 6, 2024
in Health
All-Oral AML Regimen Shows Promise for Older, Unfit Patients
Share on FacebookShare on Twitter

An all-oral combination of decitabine-cedazuridine (Inqovi) plus venetoclax (Venclexta) was active and safe in older or unfit acute myeloid leukemia (AML) patients deemed ineligible for intensive chemotherapy, results of a phase II trial suggested.

In the ongoing, single-center study, 64% of the 47 evaluable newly diagnosed patients responded to the combination, with complete remissions or complete remissions with incomplete recovery (CR/CRi) in 57%, reported Farhad Ravandi, MD, of MD Anderson Cancer Center in Houston, and colleagues.

In 13 patients with relapsed or refractory disease, 46% responded, including CR/CRi’s in all of these patients, according to findings published in Lancet Haematology.

The safety profile consisted mostly of gastrointestinal side effects, myelosuppression, and infections, which the researchers said were “in line with expectations” for the combination of decitabine-cedazuridine (a chemotherapy plus a cytidine deaminase inhibitor) plus venetoclax (a BCL-inhibitor).

The most common grade ≥3 treatment-emergent adverse events (AEs) were febrile neutropenia (18%), pneumonia (13%), respiratory failure (8%), bacteremia (6%), and sepsis (6%). Three deaths from sepsis, gastrointestinal hemorrhage, and respiratory failure occurred in patients in remission and were considered to be potentially treatment related.

If the current findings are confirmed in a multicenter phase III trial, the regimen “could become the new standard of care” for these older AML patients who are ineligible for intensive chemotherapy, wrote Anna Candoni, MD, of the University of Modena and Reggio Emilia in Italy, in an accompanying comment. “This new total oral regimen would be an additional and very important step forward in the treatment of acute myeloid leukemia in older or unfit patients.”

However, Candoni cautioned that the infectious complications observed in the trial were “not negligible.”

“It would be very important for future total oral treatment trials to pay special attention to the issues of infectious complications and hematological toxicity, by providing detailed information on the anti-infectious prophylaxis and its preventive effect and on the best use of granulocyte growth factors,” she added.

For the AE of myelosuppression, Ravandi and colleagues said that they “strongly encourage the use of triple anti-infective prophylaxis (i.e., antiviral, antibacterial, and mold-active triazole antifungal) to minimize these risks” and noted that “although the optimal duration of venetoclax per cycle has not been determined, these data suggest remissions can be maintained with shorter durations of venetoclax in patients who experience difficulties with myelosuppression.”

Oral venetoclax (400 mg) was given for 21 to 28 days of 28-day cycles, but a reduction in the duration of venetoclax administration was needed for most patients beyond the first cycle following remission. Beyond cycle five, most patients were receiving either 5 or 7 days of venetoclax per cycle. (Decitabine (35 mg)/cedazuridine (100 mg) was given for the first 5 days of each cycle.)

The phase II study enrolled 62 patients with newly diagnosed AML who were not eligible for intensive chemotherapy or with relapsed or refractory AML. Reasons patients could not receive chemotherapy included age (≥75 years), performance status (ECOG 2-3), or major comorbidities.

The cohort “was representative of an older acute myeloid leukemia population at high risk of poor outcomes,” Ravandi and colleagues observed.

Participants had a median age of 78 years, and 58% were men, while 85% were white, 6% were Black, and 3% were Asian. Patients had a number of unfavorable prognostic factors: 77% had an adverse European LeukemiaNet 2022 risk classification, 39% previously had myelodysplastic syndromes, 19% previously failed treatment with a hypomethylating agent, 16% had therapy-related AML, and 18% had TP53 mutations.

With a median follow-up of 18.3 months, median overall survival (OS) reached 11.5 months in the newly diagnosed cohort. Among those with CR/CRi, the relapse-free survival reached 12 months and median duration of response was 13.2 months.

In the relapsed or refractory group, median OS was 7.2 months, relapse-free survival was 4.6 months, and duration of response was 5.4 months.

The main trial limitation was that it was done at a single, large academic center with a relatively small number of patients, particularly in the relapsed or refractory cohort, Ravandi and co-authors acknowledged.

But they noted that the frontline results in this study were similar to those seen with other venetoclax-based regimens, such as azacitidine plus venetoclax in the VIALE-A trial. That study established parenteral azacitidine plus venetoclax as the new standard of care in older or unfit patients, with a reported composite complete remission rate of 66.4% and a median OS of 14.7 months.

“Compared with parenteral regimens, this fully oral regimen has the potential advantages of less hospital visits and shorter inpatient stays. In turn, this could lead to improved quality of life and preservation of functional status in older patients with acute myeloid leukemia or those with substantial comorbidities,” Ravandi’s group stated.

author['full_name']

Mike Bassett is a staff writer focusing on oncology and hematology. He is based in Massachusetts.

Disclosures

The trial was supported by a grant from MD Anderson Cancer Center, the Myelodysplastic Syndrome/Acute Myeloid Leukaemia Moon Shot, Leukemia SPORE, Taiho Oncology, and Astex Pharmaceuticals.

Ravandi disclosed relationships with Astex Pharmaceuticals and Taiho Oncology. Co-authors disclosed relationships with, and/or support from, multiple industry entities, including Astex Pharmaceuticals.

Candoni disclosed relationships with AbbVie, Astellas, Janssen, Jazz, Celgene, Gilead, Pfizer, Incyte, and Amgen.

Primary Source

The Lancet Haematology

Source Reference: Bazinet A, et al “Oral decitabine and cedazuridine plus venetoclax for older or unfit patients with acute myeloid leukaemia: a phase 2 study” Lancet Haematol 2024; DOI: 10.1016/S2352-3026(24)00033-4.

Secondary Source

The Lancet Haematology

Source Reference: Candoni A “Fully oral regimen with decitabine and cedazuridine plus venetoclax: a new step forward for older or unfit patients with acute myeloid leukaemia” Lancet Haematol 2024; DOI: 10.1016/S2352-3026(24)00060-7.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : MedPageToday – https://www.medpagetoday.com/hematologyoncology/leukemia/109025

Tags: All-OralhealthRegimen
Previous Post

Why Hospitals in Many States With Legal Abortion May Refuse To Perform Them

Next Post

Afib Might Be a Not-So-Pleasant Aftertaste of Sweetened Beverages

Women’s Voices Are the Only Way Forward for Climate Change Solutions: ‘As Women, We Have to Stand Up and Back Up Women’ – Ms. Magazine

Women’s Voices Are the Only Way Forward for Climate Change Solutions: ‘As Women, We Have to Stand Up and Back Up Women’ – Ms. Magazine

August 1, 2025
“A Danger to the Entire Planet”: Amid Deadly Extreme Weather, Trump’s EPA Rejects Climate Science – Democracy Now!

“A Danger to the Entire Planet”: Amid Deadly Extreme Weather, Trump’s EPA Rejects Climate Science – Democracy Now!

August 1, 2025
Ten Lifestyle Group Announces Total Voting Rights and Share Capital Update – TipRanks

Ten Lifestyle Group Announces Total Voting Rights and Share Capital Update – TipRanks

August 1, 2025
Five different countries take gold medals on a wide-open day at the swim world championships – AP News

Five Countries Triumph in a Thrilling, Unpredictable Day at the Swim World Championships

August 1, 2025
US employers slash hiring as Trump advances a punishing trade agenda – AP News

US Employers Slash Hiring as Trump’s Aggressive Trade Policies Shake the Market

August 1, 2025
Duffer Brothers and Jerry Bruckheimer Join Program for Entertainment and Technology Summit – Variety

Duffer Brothers and Jerry Bruckheimer Join Forces for an Exciting Entertainment and Technology Summit

August 1, 2025
Alabama schools enhance mental health support as students return to the classroom – WBMA

Alabama Schools Ramp Up Mental Health Support as Students Return to Classrooms

August 1, 2025
Platts­burgh town su­per­visor eyed for Dem ticket in N.Y. Assembly special election – Spectrum News

Platts­burgh town su­per­visor eyed for Dem ticket in N.Y. Assembly special election – Spectrum News

August 1, 2025
Emory orthopaedic surgeons use robotic technology to transform knee replacement surgery – Emory News Center

How Robotic Technology is Revolutionizing Knee Replacement Surgery

August 1, 2025
Carlos Correa trade grades: Astros score ‘A’ for stunning deadline deal, Twins get their salary dump – CBS Sports

Carlos Correa Trade Grades: Astros Land an ‘A’ for Blockbuster Deadline Deal, Twins Successfully Shed Salary

August 1, 2025

Categories

Archives

August 2025
MTWTFSS
 123
45678910
11121314151617
18192021222324
25262728293031
« Jul    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (749)
  • Economy (774)
  • Entertainment (21,652)
  • General (16,230)
  • Health (9,811)
  • Lifestyle (782)
  • News (22,149)
  • People (775)
  • Politics (783)
  • Science (15,987)
  • Sports (21,270)
  • Technology (15,752)
  • World (757)

Recent News

Women’s Voices Are the Only Way Forward for Climate Change Solutions: ‘As Women, We Have to Stand Up and Back Up Women’ – Ms. Magazine

Women’s Voices Are the Only Way Forward for Climate Change Solutions: ‘As Women, We Have to Stand Up and Back Up Women’ – Ms. Magazine

August 1, 2025
“A Danger to the Entire Planet”: Amid Deadly Extreme Weather, Trump’s EPA Rejects Climate Science – Democracy Now!

“A Danger to the Entire Planet”: Amid Deadly Extreme Weather, Trump’s EPA Rejects Climate Science – Democracy Now!

August 1, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version